A review of telomere length in sarcopenia and frailty

M. Lorenzi, Stefano Aurelio Bonassi, Teresa Lorenzi, Silvia Giovannini, Roberto Bernabei, G. Onder

Research output: Contribution to journalReview article

Abstract

Sarcopenia and frailty are associated with several important health-related adverse events, including disability, loss of independence, institutionalization and mortality. Sarcopenia can be considered a biological substrate of frailty, and the prevalence of both these conditions progressively increases with age. Telomeres are nucleoprotein structures located at the end of linear chromosomes and implicated in cellular ageing, shorten with age, and are associated with various age-related diseases. In addition, telomere length (TL) is widely considered a molecular/cellular hallmark of the ageing process. This narrative review summarizes the knowledge about telomeres and analyzes for the first time a possible association of TL with sarcopenia and frailty. The overview provided by the present review suggests that leukocyte TL as single measurement, calculated by quantitative real-time polymerase chain reaction (qRT-PCR), cannot be considered a meaningful biological marker for complex, multidimensional age-related conditions, such as sarcopenia and frailty. Panels of biomarkers, including TL, may provide more accurate assessment and prediction of outcomes in these geriatric syndromes in elderly people.
Original languageEnglish
Pages (from-to)209-221
Number of pages13
JournalBiogerontology
Volume19
Publication statusPublished - 2018

Fingerprint

Sarcopenia
Telomere
Cell Aging
Biomarkers
Institutionalization
Nucleoproteins
Geriatrics
Real-Time Polymerase Chain Reaction
Leukocytes
Chromosomes
Outcome Assessment (Health Care)
Mortality
Health

Cite this

Lorenzi, M., Bonassi, S. A., Lorenzi, T., Giovannini, S., Bernabei, R., & Onder, G. (2018). A review of telomere length in sarcopenia and frailty. Biogerontology, 19, 209-221.

A review of telomere length in sarcopenia and frailty. / Lorenzi, M.; Bonassi, Stefano Aurelio; Lorenzi, Teresa; Giovannini, Silvia; Bernabei, Roberto; Onder, G.

In: Biogerontology, Vol. 19, 2018, p. 209-221.

Research output: Contribution to journalReview article

Lorenzi, M, Bonassi, SA, Lorenzi, T, Giovannini, S, Bernabei, R & Onder, G 2018, 'A review of telomere length in sarcopenia and frailty', Biogerontology, vol. 19, pp. 209-221.
Lorenzi M, Bonassi SA, Lorenzi T, Giovannini S, Bernabei R, Onder G. A review of telomere length in sarcopenia and frailty. Biogerontology. 2018;19:209-221.
Lorenzi, M. ; Bonassi, Stefano Aurelio ; Lorenzi, Teresa ; Giovannini, Silvia ; Bernabei, Roberto ; Onder, G. / A review of telomere length in sarcopenia and frailty. In: Biogerontology. 2018 ; Vol. 19. pp. 209-221.
@article{02c6deb5f21e4366b4f99655cf0936bc,
title = "A review of telomere length in sarcopenia and frailty",
abstract = "Sarcopenia and frailty are associated with several important health-related adverse events, including disability, loss of independence, institutionalization and mortality. Sarcopenia can be considered a biological substrate of frailty, and the prevalence of both these conditions progressively increases with age. Telomeres are nucleoprotein structures located at the end of linear chromosomes and implicated in cellular ageing, shorten with age, and are associated with various age-related diseases. In addition, telomere length (TL) is widely considered a molecular/cellular hallmark of the ageing process. This narrative review summarizes the knowledge about telomeres and analyzes for the first time a possible association of TL with sarcopenia and frailty. The overview provided by the present review suggests that leukocyte TL as single measurement, calculated by quantitative real-time polymerase chain reaction (qRT-PCR), cannot be considered a meaningful biological marker for complex, multidimensional age-related conditions, such as sarcopenia and frailty. Panels of biomarkers, including TL, may provide more accurate assessment and prediction of outcomes in these geriatric syndromes in elderly people.",
author = "M. Lorenzi and Bonassi, {Stefano Aurelio} and Teresa Lorenzi and Silvia Giovannini and Roberto Bernabei and G. Onder",
year = "2018",
language = "English",
volume = "19",
pages = "209--221",
journal = "Biogerontology",
issn = "1389-5729",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - A review of telomere length in sarcopenia and frailty

AU - Lorenzi, M.

AU - Bonassi, Stefano Aurelio

AU - Lorenzi, Teresa

AU - Giovannini, Silvia

AU - Bernabei, Roberto

AU - Onder, G.

PY - 2018

Y1 - 2018

N2 - Sarcopenia and frailty are associated with several important health-related adverse events, including disability, loss of independence, institutionalization and mortality. Sarcopenia can be considered a biological substrate of frailty, and the prevalence of both these conditions progressively increases with age. Telomeres are nucleoprotein structures located at the end of linear chromosomes and implicated in cellular ageing, shorten with age, and are associated with various age-related diseases. In addition, telomere length (TL) is widely considered a molecular/cellular hallmark of the ageing process. This narrative review summarizes the knowledge about telomeres and analyzes for the first time a possible association of TL with sarcopenia and frailty. The overview provided by the present review suggests that leukocyte TL as single measurement, calculated by quantitative real-time polymerase chain reaction (qRT-PCR), cannot be considered a meaningful biological marker for complex, multidimensional age-related conditions, such as sarcopenia and frailty. Panels of biomarkers, including TL, may provide more accurate assessment and prediction of outcomes in these geriatric syndromes in elderly people.

AB - Sarcopenia and frailty are associated with several important health-related adverse events, including disability, loss of independence, institutionalization and mortality. Sarcopenia can be considered a biological substrate of frailty, and the prevalence of both these conditions progressively increases with age. Telomeres are nucleoprotein structures located at the end of linear chromosomes and implicated in cellular ageing, shorten with age, and are associated with various age-related diseases. In addition, telomere length (TL) is widely considered a molecular/cellular hallmark of the ageing process. This narrative review summarizes the knowledge about telomeres and analyzes for the first time a possible association of TL with sarcopenia and frailty. The overview provided by the present review suggests that leukocyte TL as single measurement, calculated by quantitative real-time polymerase chain reaction (qRT-PCR), cannot be considered a meaningful biological marker for complex, multidimensional age-related conditions, such as sarcopenia and frailty. Panels of biomarkers, including TL, may provide more accurate assessment and prediction of outcomes in these geriatric syndromes in elderly people.

M3 - Review article

VL - 19

SP - 209

EP - 221

JO - Biogerontology

JF - Biogerontology

SN - 1389-5729

ER -